Gabapentin Market Report 2026
Download Free Sample Buy Now
Gabapentin Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gabapentin Market Report 2026

Global Outlook – By Type (Generic, Branded), By Dosage Form (Tablet, Capsule, Oral Solution), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Gabapentin Market Overview

• Gabapentin market size has reached to $3.01 billion in 2025

• Expected to grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: The Increasing Prevalence Of Epilepsy Is Fueling The Growth Of The Market Due To Rising Cases Driven By An Aging Population And The Need For Effective Seizure Control

• Market Trend: Advancements In Bioequivalent Gabapentin Tablets Boost Neurological Treatment Options

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gabapentin Market?

Gabapentin is a prescription medication that is primarily used to treat nerve pain, epilepsy, and restless legs syndrome. It targets nerve signals and brain chemicals to control seizures and ease nerve pain. It is widely used to treat nerve-related pain from shingles and diabetic neuropathy. Gabapentin helps stabilize brain activity and reduce abnormal nerve excitability.

The main types of gabapentin are generic and branded. Generic drugs contain the same active ingredients and dosage as branded ones, providing a more affordable yet equally effective alternative for medications. It is available in various dosage forms such as tablets, capsules, and oral solution and is distributed through several distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, for various applications such as epilepsy, neuropathic pain, restless legs syndrome, and others.

Gabapentin Market Global Report 2026 Market Report bar graph

What Is The Gabapentin Market Size and Share 2026?

The gabapentin market size has grown strongly in recent years. It will grow from $3.01 billion in 2025 to $3.26 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to epilepsy treatment adoption, neuropathic pain prevalence, generic drug availability, physician prescribing patterns, chronic disease burden.

What Is The Gabapentin Market Growth Forecast?

The gabapentin market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to aging population, diabetic neuropathy growth, generic penetration, outpatient pain management, telemedicine prescriptions. Major trends in the forecast period include rising use in neuropathic pain management, increased demand for generic formulations, expansion of chronic pain treatment programs, growth of oral solid dosage forms, increased prescriptions for neurological disorders.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gabapentin Market Segmentation

1) By Type: Generic, Branded

2) By Dosage Form: Tablet, Capsule, Oral Solution

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Other Applications

Subsegments:

1) By Generic: Gabapentin Immediate Release (IR), Gabapentin Extended Release (ER), Gabapentin Capsules, Gabapentin Tablets, Gabapentin Oral Solution

2) By Branded: Neurontin, Gralise, Horizant, Other Branded Formulations

What Is The Driver Of The Gabapentin Market?

The increasing prevalence of epilepsy is expected to drive the growth of the gabapentin market going forward. Epilepsy is a brain disorder characterized by repeated seizures caused by irregular electrical activity in the brain. Epilepsy cases are rising mainly due to the growing elderly population, as aging increases the risk of neurological disorders that cause seizures. Gabapentin controls epilepsy by calming abnormal nerve activity in the brain and lowering seizure-causing signals. It works by targeting calcium channels to help prevent seizure occurrence. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-intergovernmental organization, around 50 million people globally have epilepsy, nearly 80% of those with epilepsy live in low- and middle-income countries, and up to 70% could live seizure-free if properly diagnosed and treated. Each year, an estimated 5 million people are newly diagnosed with epilepsy worldwide; in high-income countries this rate is about 49 per 100,000, while in low- and middle-income countries it can be as high as 139 per 100,000. Therefore, the increasing prevalence of epilepsy is driving the growth of the gabapentin industry.

Key Players In The Global Gabapentin Market

Major companies operating in the gabapentin market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Ipca Laboratories Private Limited, Granules India Limited, Medley Pharmaceuticals Limited, Wockhardt Limited, Epic Pharma LLC, Healing Pharma India Pvt. Ltd., Rochem International Inc., Accord Healthcare Limited, Strides Pharma Science Limited, Ascend Laboratories LLC

Global Gabapentin Market Trends and Insights

Major companies operating in the gabapentin market are focusing on developing advanced formulations, such as bioequivalent tablets, to enhance therapeutic efficacy and expand treatment options for neurological conditions. Bioequivalent tablets are generic drugs that release an identical dose of the active ingredient into the bloodstream with the same speed and efficiency as the branded version, guaranteeing similar safety and therapeutic effects. For instance, in March 2024, Strides Pharma Science Limited, an India-based pharmaceutical company, launched Gabapentin Tablets USP in 600 mg and 800 mg strengths, which received approval from the United States Food & Drug Administration (USFDA) to expand the neurology portfolio in the US market. This innovative gabapentin features enhanced bioavailability, precise dosing, and patient-friendly administration, enabling more consistent therapeutic outcomes, improved symptom control, and greater convenience for long-term therapy. Gabapentin tablets USP, 600 mg, offer versatile therapeutic potential, providing effective management of a range of neurological conditions such as neuropathic pain and partial seizures through reliable dosing and proven clinical efficacy.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gabapentin Market?

In September 2023, Adalvo, a Malta-based pharmaceutical company, collaborated with Lotus Pharmaceutical to enhance lives through accessible and innovative neurological care. The partnership aims to offer a convenient, once-daily treatment for postherpetic neuralgia by launching Gabapentin ER in South Korea, addressing unmet needs, and expanding its market presence in neurology. Lotus Pharmaceutical is a Taiwan-based manufacturer of gabapentin extended-release tablets.

Regional Insights

North America was the largest region in the gabapentin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gabapentin Market?

The gabapentin market consists of sales of gabapentin immediate-release, gabapentin extended-release, and oral solution. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gabapentin Market Report 2026?

The gabapentin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gabapentin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gabapentin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.26 billion
Revenue Forecast In 2035 $4.45 billion
Growth Rate CAGR of 8.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Dosage Form, Distribution Channel, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals L
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gabapentin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gabapentin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gabapentin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gabapentin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Use In Neuropathic Pain Management

4.2.2 Increased Demand For Generic Formulations

4.2.3 Expansion Of Chronic Pain Treatment Programs

4.2.4 Growth Of Oral Solid Dosage Forms

4.2.5 Increased Prescriptions For Neurological Disorders

5. Gabapentin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Retail Pharmacies

5.4 Online Pharmacies

5.5 Homecare Settings

6. Gabapentin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gabapentin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gabapentin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gabapentin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gabapentin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gabapentin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gabapentin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gabapentin Market Segmentation

9.1. Global Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generic, Branded

9.2. Global Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablet, Capsule, Oral Solution

9.3. Global Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.4. Global Gabapentin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Other Applications

9.5. Global Gabapentin Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gabapentin Immediate Release (IR), Gabapentin Extended Release (ER), Gabapentin Capsules, Gabapentin Tablets, Gabapentin Oral Solution

9.6. Global Gabapentin Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neurontin, Gralise, Horizant, Other Branded Formulations

10. Gabapentin Market Regional And Country Analysis

10.1. Global Gabapentin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gabapentin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gabapentin Market

11.1. Asia-Pacific Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gabapentin Market

12.1. China Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gabapentin Market

13.1. India Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gabapentin Market

14.1. Japan Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gabapentin Market

15.1. Australia Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gabapentin Market

16.1. Indonesia Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gabapentin Market

17.1. South Korea Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gabapentin Market

18.1. Taiwan Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gabapentin Market

19.1. South East Asia Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gabapentin Market

20.1. Western Europe Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gabapentin Market

21.1. UK Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gabapentin Market

22.1. Germany Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gabapentin Market

23.1. France Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gabapentin Market

24.1. Italy Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gabapentin Market

25.1. Spain Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gabapentin Market

26.1. Eastern Europe Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gabapentin Market

27.1. Russia Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gabapentin Market

28.1. North America Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gabapentin Market

29.1. USA Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gabapentin Market

30.1. Canada Gabapentin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gabapentin Market

31.1. South America Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gabapentin Market

32.1. Brazil Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gabapentin Market

33.1. Middle East Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gabapentin Market

34.1. Africa Gabapentin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gabapentin Market, Segmentation By Type, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gabapentin Market Regulatory and Investment Landscape

36. Gabapentin Market Competitive Landscape And Company Profiles

36.1. Gabapentin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gabapentin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gabapentin Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Mylan Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Gabapentin Market Other Major And Innovative Companies

Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Ipca Laboratories Private Limited, Granules India Limited, Medley Pharmaceuticals Limited, Wockhardt Limited, Epic Pharma LLC, Healing Pharma India Pvt. Ltd., Rochem International Inc., Accord Healthcare Limited, Strides Pharma Science Limited

38. Global Gabapentin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gabapentin Market

40. Gabapentin Market High Potential Countries, Segments and Strategies

40.1 Gabapentin Market In 2030 - Countries Offering Most New Opportunities

40.2 Gabapentin Market In 2030 - Segments Offering Most New Opportunities

40.3 Gabapentin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gabapentin Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gabapentin Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gabapentin Market, Supply Chain Analysis
  • Table 4: Global Gabapentin Market, Major Raw Material Providers
  • Table 5: Global Gabapentin Market, Major Resource Providers
  • Table 6: Global Gabapentin Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gabapentin Market, Major Distributors And Channel Partners
  • Table 8: Global Gabapentin Market, Key Technologies & Future Trends
  • Table 9: Global Gabapentin Market, Major Trends
  • Table 10: Global Gabapentin Market, Major End Users
  • Table 11: Global Gabapentin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gabapentin Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gabapentin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gabapentin Market - TAM, US$ Billion, 2025
  • Table 15: Global Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gabapentin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gabapentin Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gabapentin Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gabapentin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gabapentin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Gabapentin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Gabapentin Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 99: Mylan Inc. Financial Performance
  • Table 100: Apotex Inc. Financial Performance
  • Table 101: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Table 102: Global Gabapentin Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Gabapentin Market, Competitive Dashboard
  • Table 104: Global Gabapentin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Table 107: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Gabapentin Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gabapentin Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gabapentin Market, Supply Chain Analysis
  • Figure 4: Global Gabapentin Market, Major Raw Material Providers
  • Figure 5: Global Gabapentin Market, Major Resource Providers
  • Figure 6: Global Gabapentin Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gabapentin Market, Major Distributors And Channel Partners
  • Figure 8: Global Gabapentin Market, Key Technologies & Future Trends
  • Figure 9: Global Gabapentin Market, Major Trends
  • Figure 10: Global Gabapentin Market, Major End Users
  • Figure 11: Global Gabapentin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gabapentin Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gabapentin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gabapentin Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gabapentin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gabapentin Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gabapentin Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gabapentin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gabapentin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Gabapentin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gabapentin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gabapentin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Gabapentin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Gabapentin Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 99: Mylan Inc. Financial Performance
  • Figure 100: Apotex Inc. Financial Performance
  • Figure 101: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Figure 102: Global Gabapentin Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Gabapentin Market, Competitive Dashboard
  • Figure 104: Global Gabapentin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030
  • Figure 107: Global, Gabapentin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Glycomic Therapeutics Market Report 2026 - Global Outlook – By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (...

Glycopeptide Antibiotics Market Report 2026 - Global Outlook – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure I...

Antiglaucoma Drugs Market Report 2026 - Global Outlook – By Mode Of Availability (Hospital Prescription Drugs, Non-Prescription Drugs), By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medic...

Guacamole Market Report 2026 - Global Outlook – By Nature (Organic, Conventional), By Packaging (Glass Bottles, Glass Jars, Plastic Containers, Stand-Up Pouches), By Distribution Channels (Supermarkets/Hypermarkets, Conv...

Glufosinate Market Report 2026 - Global Outlook – By Crop Type (Genetically Modified Crops, Conventional Crops), By Formulation (Aqueous Suspension, Liquid, Suspension Concentrate, Soluble (Liquid) Concentrate, Other For...

Companion Animal Pharmaceuticals Market Report 2026 - Global Outlook – By Product Type (Therapeutic Drugs, Vaccines, Other Product Types), By Animal Type (Dogs, Cats, Equines, Other Animal Types), By Route Of Administrat...

GMP Cell Therapy Consumables Market Report 2026 - Global Outlook – By Product (Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products), By Cell Therapy (NK Cell Therapy...

Carboprost Tromethamine Market Report 2026 - Global Outlook – By Dosage Form (Single-Dose Vials, Multi-Dose Vials), By Distribution Channel (Hospital Pharmacies, Institutional Or Government Supply Channels), By Applicati...

Frequently Asked Questions

The Gabapentin market was valued at $3.01 billion in 2025, increased to $3.26 billion in 2026, and is projected to reach $4.45 billion by 2030.

The global Gabapentin market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $4.45 billion by 2035.

Some Key Players in the Gabapentin market Include, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Ipca Laboratories Private Limited, Granules India Limited, Medley Pharmaceuticals Limited, Wockhardt Limited, Epic Pharma LLC, Healing Pharma India Pvt. Ltd., Rochem International Inc., Accord Healthcare Limited, Strides Pharma Science Limited, Ascend Laboratories LLC .

Major trend in this market includes: Advancements In Bioequivalent Gabapentin Tablets Boost Neurological Treatment Options. For further insights on this market. request a sample here

North America was the largest region in the gabapentin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gabapentin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us